August 14, 2023
Research Paper
Foley & Lardner

DEA: Potential New Telemedicine Special Registration for Controlled Substances Prescribing to be Discussed in Special Listening Sessions

The Drug Enforcement Administration (DEA) is signaling its consideration of a separate Special Registration for telemedicine prescribing without the prerequisite of an in-person examination. On August 4, 2023, the DEA released a pre-publication Notice of Meeting, announcing plans to conduct public sessions this upcoming fall. In this article, Foley & Lardner delve into the DEA’s considerations and provide insights on the scheduled public listening sessions set for Tuesday, September 12, 2023.

  Download PDF









Related Resources


Research Papers


What is the State of Digital Health Funding in 2023?
April 5, 2023
Foley & Lardner
With the pandemic, there came a digital health explosion, with companies working swiftly to bring new technologies to light that would pave the way forward in telehealth and other critical areas.

   Download PDF
Research Papers


Use of Telehealth During the COVID-19 Era
January 19, 2023
Agency for Healthcare Research and Quality
Telehealth is remotely delivered and synchronous medical services (telephone/audio, video visit) between a patient and a healthcare provider in an ambulatory setting (e.

   Download PDF
Research


Strategies for Quality Care
June 7, 2022
Strategies for Quality Care
Strategies for Quality Care® is a centralized source of solutions and resources to help health systems achieve the goals of value-based care and the Quadruple Aim.